Eric Joseph Avery
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
-
- Lung Cancer Treatments and Mutations 2
- Lung Cancer Diagnosis and Treatment 1
- Co-authors
- Sean Dolan (5 shared papers)Árpád Illés (4 shared papers)Gerardo Musuraca (5 shared papers)Małgorzata Wach (5 shared papers)Javier de la Serna (5 shared papers)Abraham O. Jacob (5 shared papers)Andrzej Pluta (4 shared papers)Daniel Lysák (5 shared papers)
- Journals
- HemaSphere (2 papers)Journal of Clinical Oncology (2 papers)American Journal of Hematology (1 paper)Hematological Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesSouth KoreaHungary
In The Last Decade
Eric Joseph Avery
13 papers receiving 581 citations
Eric Joseph Avery's Hit Papers
Peers
Comparison fields: 5 of 45
- Genetics 371
- Pulmonary and Respiratory Medicine 86
- Oncology 46
- Social Psychology 27
- Pathology and Forensic Medicine 18
Countries citing papers authored by Eric Joseph Avery
This map shows the geographic impact of Eric Joseph Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Joseph Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Joseph Avery more than expected).
Fields of papers citing papers by Eric Joseph Avery
This network shows the impact of papers produced by Eric Joseph Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Joseph Avery. The network helps show where Eric Joseph Avery may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Joseph Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia Hit paper breakdown → | 2020 | 308 |
| 2 | Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study Hit paper breakdown → | 2024 | 92 |
| 3 | 2022 | 80 | |
| 4 | Transgender Health and HIV Prevention: Needs Assessment Studies from Transgender Communities Across the United States | 2006 | 37 |
| 5 | 2019 | 24 | |
| 6 | 2009 | 19 | |
| 7 | 2021 | 14 | |
| 8 | 2016 | 7 | |
| 9 | 2020 | 6 | |
| 10 | Ascend Phase 3 Study of Acalabrutinib vs Investigator's Choice of Rituximab Plus Idelalisib (IDR) or Bendamustine (BR) in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) | 2020 | 5 |
| 11 | 2005 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2021 | 0 |
About Eric Joseph Avery
Eric Joseph Avery is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Social Psychology, Dermatology and Cancer Research, having authored 14 papers that have together received 595 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Lung Cancer Treatments and Mutations (2 papers), LGBTQ Health, Identity, and Policy (2 papers), Lung Cancer Diagnosis and Treatment (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), HIV/AIDS Research and Interventions (1 paper), MRI in cancer diagnosis (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Genetics (371 citations), Pulmonary and Respiratory Medicine (86 citations), Oncology (46 citations), Social Psychology (27 citations) and Pathology and Forensic Medicine (18 citations). Eric Joseph Avery has collaborated with scholars based in United States, South Korea and Hungary. Frequent co-authors include Sean Dolan, Árpád Illés, Gerardo Musuraca, Małgorzata Wach, Javier de la Serna, Abraham O. Jacob, Andrzej Pluta, Daniel Lysák, Wojciech J. Jurczak and Paolo Ghia. Their work appears in journals such as HemaSphere, Journal of Clinical Oncology, American Journal of Hematology, Hematological Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.